ENDRA Life Sciences Inc. — Director's Dealing 2020

Oct 26, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ENDRA Life Sciences Inc. (NDRA)
CIK: 0001681682
Period of Report: 2020-10-22

Reporting Person: Basenese Lou (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-10-22	Stock Option (right to buy)	$0.73	A	50000	Acquired	2030-10-22	Common Stock (50000)	Direct

Footnotes

F1: This stock option grant becomes exercisable in three equal annual installments beginning on October 22, 2021.